The Federal Trade Commission (FTC) has issued a warning to Savannah Chrisley, a well-known celebrity, over her weight loss website. The FTC claims that Chrisley made false and misleading statements about the effectiveness of GLP-1 drugs, which are prescription medications. The warning letter, obtained by TMZ, highlights several issues with Chrisley's website, GoodGirlRX. The FTC took exception to Chrisley's use of phrases such as 'FDA-approved meds' and 'clinically proven GLP-1 results', which are not accurate representations of compounded drug products. The FTC advised Chrisley that these products are not FDA-approved and that she was implying they had been evaluated for safety and effectiveness, which is not the case. Chrisley was given 15 business days to make the necessary corrections or face legal action. It appears that Chrisley has taken the warning seriously, as her website has since made changes to comply with the FTC's guidelines. For instance, the phrasing has been updated to 'clinically studied results' and disclaimers have been added to indicate that the GLP-1 drugs are not FDA-approved. Chrisley has responded to the situation by stating that the issue was about website wording, not patient safety, and that there were no fines or disciplinary actions taken. She also expressed pride in helping women access licensed physicians and welcomed the FTC's guidance.
